Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.

Pharmacogenomics - 1 Apr 2011

Ramsey Timothy L, Meltzer Herbert Y, Brock Guy N, Mehrotra Bharat, Jayathilake Karu, Bobo William V, Brennan Mark D

Abstract excerpt

AIM: This study evaluated the impact of SULT4A1 gene variation on psychopathology and antipsychotic drug response in Caucasian subjects from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study and a replication sample. PATIENTS & METHODS: SULT4A1 haplotypes were determin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase I as Topic

Share to Olanzapine

Share to Randomized Controlled Trials as Topic

Share to Risperidone

Share to Sulfotransferases

Source

Open in PubMed Open full text

Identifiers

PMID: 21521020
DOI: 10.2217/pgs.10.205
PMCID: PMC3168511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21521020-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.PMID 21521020Read ↗

SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response.Semantic proximity Read ↗

Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.Semantic proximity Read ↗

Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia.Semantic proximity Read ↗

Pharmacogenetics and outcome with antipsychotic drugsSemantic proximity Read ↗

The pharmacogenetics of antipsychotic treatment.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.Semantic proximity Read ↗

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.Semantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Pharmacogenetics of AntipsychoticsSemantic proximity Read ↗

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.Semantic proximity Read ↗

Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene.Semantic proximity Read ↗

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.